跳至主要内容
临床试验/NCT01957670
NCT01957670撤回不适用

Pilot, Open-label, Single-Arm Study Designed to Clinically Evaluate Various Lacrima Medical Device Prototypes in Adult Patients With Dry Eye Syndrome

Lacrima Medical LTD2 个研究点 分布在 1 个国家开始时间: 2014年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
2
主要终点
Lower Tear Meniscus Height using Optical Coherence Tomography

研究概览

简要总结

The study will assess the safety, tolerability and feasibility of Lacrima investigational medical device to treat dry eye patients

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Main Inclusion Criteria:
  • Male or female, 18 years of age and over at screening
  • Diagnosis of mild to moderate Dry Eye, as defined by:
  • Positive corneal fluorescein staining , defined as a corneal punctate fluorescein staining score of ≥3 in either eye by the National Eye Institute evaluation scale summed over 5 areas, each with a 0-3 scoring scale; AND
  • Schirmer Test score (with anesthesia, 5 minutes < 5 mm either eye) ; AND
  • OSDI score of ≥12 and OSDI score of <33

排除标准

  • Persistent intraocular inflammation or infection including conjunctivitis at the time of the study or 2 weeks prior to study start.
  • Any concomitant active or history of eye disease including, but not limited to lid abnormalities, nasolacrimal obstruction, active ulcer, glaucoma or ocular herpes simplex virus infection
  • Patients currently using topical steroidal or anti-inflammatory eye drops for 1 month prior to screening
  • Receipt of any type of topical artificial eye drops within 3 days prior to screening
  • Receipt of topical cyclosporine eye drops within 3 months prior to screening

结局指标

主要结局

Lower Tear Meniscus Height using Optical Coherence Tomography

时间窗: up to 8 hours

次要结局

  • Visual Analog Scale score(up to 8 hours)

研究者

发起方
Lacrima Medical LTD
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验